Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06100107
Other study ID # EK-1288/14
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 9, 2013
Est. completion date January 15, 2016

Study information

Verified date October 2023
Source University Hospital, Motol
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim is to evaluate the efficacy of Mirror Therapy on pain reduction and hand function in subjects with unilateral upper extremity Complex Regional Pain Syndrome Type I.


Description:

Subjects were randomly divided into two groups. Group A carried out a ten-minute Mirror Therapy exercise daily, for a total duration of six weeks. Group B acted as a control group for six weeks followed by six weeks of Mirror Therapy with the same characteristics as Group A. Upper extremity active range of motion, strength, dexterity, limb volume, right-left temperature difference, and health-related quality of life were evaluated before and after each period. Daily records on the visual analogue scale were used for pain evaluation. Effectiveness was calculated using mixed-effects modelling for between-group comparisons and within-group variability and identifying significant predictors.


Recruitment information / eligibility

Status Completed
Enrollment 27
Est. completion date January 15, 2016
Est. primary completion date September 30, 2015
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - diagnosis of CRPS I based on the Budapest criteria Exclusion Criteria: - failure to meet the diagnostic Budapest clinical criteria for CRPS I - previous use of Mirror Therapy prior to the commencement of this study - substantial difficulties in cooperation - a significant change to the subjects' treatment regimen, outside of the study design

Study Design


Intervention

Other:
Mirror Therapy exercise
Mirror Therapy for the upper limb involves the use of a mirror to create a reflected image of the unaffected arm, making it appear as if both arms are moving symmetrically. During the therapy, the patient places their affected arm behind the mirror and their unaffected arm in front. While focusing on the mirror reflection, the patient performs various movements with the unaffected arm, giving the illusion that the affected arm is moving normally.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Motol

Outcome

Type Measure Description Time frame Safety issue
Primary Pain perception The participants in both groups made daily accounts of their pain level using 10 cm long visual analog scale (VAS) at rest as well as typical pain level during hand movement. Recordings performed every day from day 0 to day 42 (Group A) and from day 0 to day 84 (Group B); Follow-up on day 72 (Group A) and day 114 (Group B).
Primary Active Range of Motion Three attributes were measured: maximal active range of wrist flexion and extension (°) determined with goniometer measuring the angle between forearm and metacarpal bones On day 0 (Group A, Group B); on day 42 (Group A, Group B); on day 84 (Group B)
Primary Strength The outcome parameter is the highest pressure (bar) performed during one maximal grip. On day 0 (Group A, Group B); on day 42 (Group A, Group B); on day 84 (Group B)
Primary Dexterity Dexterity was evaluated by using a nine-hole PegBoard. The time taken to complete this task was measured. On day 0 (Group A, Group B); on day 42 (Group A, Group B); on day 84 (Group B)
Primary Volume of hand and forearm The volumetric measurements are based on the principle of water displacement. On day 0 (Group A, Group B); on day 42 (Group A, Group B); on day 84 (Group B)
Primary Temperature Temperature was measured bilaterally in the thenar area using an infrared thermometer. On day 0 (Group A, Group B); on day 42 (Group A, Group B); on day 84 (Group B)
Primary Health-related Quality of Life Determined using the European Quality of Life-5 Dimensions-3 Levels questionnaire. A range of 0-100% is used, where a higher score means a better outcome. On day 0 (Group A, Group B); on day 42 (Group A, Group B); on day 84 (Group B)
See also
  Status Clinical Trial Phase
Terminated NCT00006289 - Neurotropin to Treat Chronic Neuropathic Pain Phase 2
Recruiting NCT05877612 - Efficacy of Spinal Cord Stimulation in Burst Mode in the Treatment of Complex Regional Pain Syndromes Type 1 of the Upper Limbs
Terminated NCT03309774 - Complex Regional Pain Syndrome in Children: Impact of Bergès Relaxation on the Autonomic Balance N/A
Completed NCT00625976 - Graded Exposure (GEXP) in Vivo Versus Physiotherapy in Complex Regional Pain Syndrome Type I (CRPS-I) N/A
Not yet recruiting NCT06302920 - Effect of Kinesiotaping on Pain,Edema and Kinesiophobia in Patients With Complex Regional Pain Syndrome N/A
Recruiting NCT04703647 - Longitudinal Follow-up Study About Complex Regional Pain Syndrome (CRPS) Patients
Completed NCT03377504 - Clinical Evaluation of the Effects of Mirror Therapy in Patients With Complex Regional Pain Syndrome (CRPS) Type 1 N/A
Recruiting NCT06306157 - Low Dose Naltrexone Therapy for Complex Regional Pain Syndrome Phase 4
Recruiting NCT05745025 - rTMS and Rehabilitation for Individuals With CRPS Type 1 N/A
Terminated NCT04667364 - Pain in Complex Regional Pain Syndrome N/A